Tu Hu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
PD-1 blockade treatment in melanoma: Mechanism of response and tumor-intrinsic resistance.
Journal: Cancer science
Published: May 29, 2024
Prognostic value of the number of biopsied sentinel lymph nodes for Chinese patients with melanoma: A single-center retrospective study.
Journal: Cancer reports (Hoboken, N.J.)
Published: July 28, 2023
Survival impact of immediate complete lymph node dissection for Chinese acral and cutaneous melanoma with micrometastasis in sentinel nodes: a retrospective study.
Journal: Clinical and experimental medicine
Published: May 03, 2023
Delineating the early dissemination mechanisms of acral melanoma by integrating single-cell and spatial transcriptomic analyses.
Journal: Nature communications
Published: April 11, 2023
Adjuvant Anti-PD-1 Immunotherapy versus Conventional Therapy for Stage III Melanoma: A Real-World Retrospective Cohort Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 29, 2022
Oncogenic alterations reveal key strategies for precision oncology in melanoma treatment.
Journal: Annals of translational medicine
Published: October 27, 2022
Comparative analysis of adjuvant therapy for stage III BRAF-mut melanoma: A real-world retrospective study from single center in China.
Journal: Cancer medicine
Published: October 18, 2022
Combination of pembrolizumab plus temozolomide therapy in unresectable and advanced melanoma: a multicenter retrospective analysis in China.
Journal: Annals of translational medicine
Published: September 28, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026